SCM
Soleus Capital Management Portfolio holdings
AUM
$2.47B
1-Year Est. Return
115.63%
This Fund
S&P 500
1 Year Est. Return
+115.63%
AUM
$2.47B
AUM Growth
+$112M
(+4.7%)
Holding
119
Top Buys
| 1 | +$104M | |
| 2 | +$63.4M | |
| 3 | +$63.3M | |
| 4 |
Krystal Biotech
KRYS
|
+$56.4M |
| 5 |
Progyny
PGNY
|
+$44.3M |
Top Sells
| 1 | +$80.6M | |
| 2 | +$74.2M | |
| 3 | +$57.1M | |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$39M |
| 5 |
GSK
GSK
|
+$31.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arcus Biosciences
RCUS
$3.11B
| $9.76M | 0.4% |
451,983
-260,000
|
|
||
52
Tango Therapeutics
TNGX
$3.11B
| $9.41M | 0.38% |
450,000
+440,000
|
|
||
53
Evolus
EOLS
$397M
| $9.23M | 0.37% |
2,245,360
+1,175,360
|
|
||
54
SOPHiA GENETICS
SOPH
$343M
| $9.16M | 0.37% |
+1,850,000
|
|
||
55
Enliven Therapeutics
ELVN
$2.19B
| $9.05M | 0.37% |
230,869
-794,131
|
|
||
56
Inhibrx
INBX
$1.4B
| $8.81M | 0.36% |
131,000
+106,000
|
|
||
57
DexCom
DXCM
$28.1B
| $8.79M | 0.36% |
140,000
-1,157,094
|
|
||
|
SEPN
58
Septerna Inc
SEPN
$1.38B
| $6.61M | 0.27% |
275,000
-108,368
|
|
||
59
Avalo Therapeutics
AVTX
$722M
| $6.6M | 0.27% |
441,978
|
|
||
60
Biodesix
BDSX
$167M
| $6.04M | 0.24% |
+416,599
|
|
||
61
Relmada Therapeutics
RLMD
$664M
| $5.86M | 0.24% |
+842,106
|
|
||
62
Cullinan Oncology
CGEM
$935M
| $5.83M | 0.24% |
+410,200
|
|
||
63
Immunovant
IMVT
$6.4B
| $5.71M | 0.23% |
230,000
-880,000
|
|
||
|
MBX
64
MBX Biosciences
MBX
$1.47B
| $5.34M | 0.22% |
178,897
-230,003
|
|
||
65
Immunic
IMUX
$193M
| $5M | 0.2% |
+450,000
|
|
||
66
Larimar Therapeutics
LRMR
$332M
| $4.8M | 0.19% |
+1,066,960
|
|
||
67
Eton Pharmaceutcials
ETON
$756M
| $4.11M | 0.17% |
+166,381
|
|
||
68
SAB Biotherapeutics
SABS
$257M
| $4.02M | 0.16% |
+1,050,000
|
|
||
69
Procept Biorobotics
PRCT
$1.5B
| $4M | 0.16% |
+160,000
|
|
||
70
Structure Therapeutics
GPCR
$2.78B
| $3.86M | 0.16% |
80,000
-10,000
|
|
||
|
TECX
71
Tectonic Therapeutic
TECX
$536M
| $3.76M | 0.15% |
+121,684
|
|
||
72
Pulmonx
LUNG
$64.2M
| $3.6M | 0.15% |
2,788,323
+750,000
|
|
||
73
Iovance Biotherapeutics
IOVA
$1.96B
| $3.51M | 0.14% |
+1,000,000
|
|
||
74
argenx
ARGX
$52.4B
| $2.56M | 0.1% |
3,500
-28,226
|
|
||
75
Karyopharm Therapeutics
KPTI
$204M
| $2.45M | 0.1% |
440,000
|
|